Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) CFO Jamie Samath sold 108 shares of the firm's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Jamie Samath also recently made the following trade(s):
- On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00.
- On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41.
Intuitive Surgical Trading Up 1.0 %
Intuitive Surgical stock opened at $542.10 on Wednesday. The firm has a market cap of $193.09 billion, a price-to-earnings ratio of 87.15, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The stock has a fifty day simple moving average of $506.81 and a two-hundred day simple moving average of $466.29.
Watch this before it gets removed
From Porter & Company | Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in ISRG. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. International Assets Investment Management LLC increased its position in Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC lifted its holdings in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB boosted its position in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC grew its stake in shares of Intuitive Surgical by 40,221.4% during the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider's stock valued at $1,184,000 after purchasing an additional 265,461 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
ISRG has been the topic of several research reports. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a "buy" rating in a report on Thursday, August 22nd. Truist Financial boosted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a report on Monday, October 14th. Finally, Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $526.06.
Read Our Latest Report on ISRG
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
